Xylem Inc (XYL) Stake Lowered by Broderick Brian C

Broderick Brian C lowered its holdings in Xylem Inc (NYSE:XYL) by 1.3% during the second quarter, Holdings Channel reports. The fund owned 55,135 shares of the industrial products company’s stock after selling 720 shares during the period. Broderick Brian C’s holdings in Xylem were worth $3,716,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Fulcrum Capital LLC grew its stake in Xylem by 1.2% during the 1st quarter. Fulcrum Capital LLC now owns 62,842 shares of the industrial products company’s stock worth $4,834,000 after buying an additional 720 shares during the last quarter. First Republic Investment Management Inc. grew its stake in Xylem by 1.8% during the 1st quarter. First Republic Investment Management Inc. now owns 40,838 shares of the industrial products company’s stock worth $3,142,000 after buying an additional 724 shares during the last quarter. IFP Advisors Inc grew its stake in Xylem by 3.1% during the 1st quarter. IFP Advisors Inc now owns 23,970 shares of the industrial products company’s stock worth $1,844,000 after buying an additional 729 shares during the last quarter. Independent Investors Inc. grew its stake in Xylem by 9.2% during the 1st quarter. Independent Investors Inc. now owns 9,470 shares of the industrial products company’s stock worth $728,000 after buying an additional 800 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its stake in Xylem by 3.2% during the 1st quarter. Nomura Asset Management Co. Ltd. now owns 27,174 shares of the industrial products company’s stock worth $2,091,000 after buying an additional 831 shares during the last quarter. Institutional investors and hedge funds own 83.37% of the company’s stock.

In other Xylem news, Director Curtis J. Crawford sold 7,500 shares of the stock in a transaction that occurred on Monday, May 14th. The stock was sold at an average price of $73.39, for a total transaction of $550,425.00. Following the completion of the sale, the director now directly owns 41,744 shares of the company’s stock, valued at approximately $3,063,592.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.81% of the stock is currently owned by company insiders.

Xylem traded down $0.15, reaching $70.04, during mid-day trading on Monday, Marketbeat reports. 127,837 shares of the company were exchanged, compared to its average volume of 1,040,596. Xylem Inc has a twelve month low of $56.54 and a twelve month high of $79.83. The company has a current ratio of 1.42, a quick ratio of 1.02 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $12.63 billion, a price-to-earnings ratio of 29.28, a PEG ratio of 1.35 and a beta of 1.09.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, May 1st. The industrial products company reported $0.51 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.51. Xylem had a return on equity of 18.31% and a net margin of 7.29%. The company had revenue of $1.22 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same period last year, the firm earned $0.39 EPS. The firm’s revenue for the quarter was up 13.6% on a year-over-year basis. equities analysts predict that Xylem Inc will post 2.89 earnings per share for the current year.

XYL has been the topic of a number of research reports. Zacks Investment Research downgraded Xylem from a “buy” rating to a “hold” rating in a research note on Monday, April 9th. Oppenheimer restated a “buy” rating and set a $82.00 price target on shares of Xylem in a research note on Tuesday, May 1st. Boenning Scattergood restated a “buy” rating and set a $90.00 price target on shares of Xylem in a research note on Tuesday, May 1st. Canaccord Genuity set a $78.00 price target on Xylem and gave the stock a “hold” rating in a research note on Tuesday, April 24th. Finally, BMO Capital Markets dropped their price target on Xylem from $86.00 to $83.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 2nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $80.20.

About Xylem

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Recommended Story: Average Daily Trade Volume Explained

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply